Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CPA3 | P15088 | 1/20 | 0.50 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.50 |
| ▸ | MME | P08473 | 4/20 | 0.49 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1109641 | 1.00 | CPA3 (0.50) | CPA3FOLH1MMEGAAMAPT | |
| SCHEMBL515921 | 1.00 | CPA3 (0.50) | CPA3FOLH1MMEGAAMAPT | |
| Hydrochloric Acid SCHEMBL28182328 | 0.98 | CPA3 (0.49) | CPA3FOLH1MMEGAAMAPT | |
| Hydrochloric Acid SCHEMBL1927540 | 0.98 | CPA3 (0.49) | CPA3FOLH1MMEGAAMAPT | |
| Hydrochloric Acid SCHEMBL1927541 | 0.98 | CPA3 (0.49) | CPA3FOLH1MMEGAAMAPT | |
| Benzenemethanethiol SCHEMBL11584239 | 0.95 | IDO1 (0.47) | CPA3FOLH1MMEGAAMAPT | |
| SCHEMBL5505220 | 0.91 | MME (0.49) | MMEGAA | |
| Cysteine SCHEMBL1927883 | 0.91 | PTGS1 (0.49) | CPA3FOLH1MME | |
| SCHEMBL14777396 | 0.86 | MEN1 (0.46) | CPA3FOLH1MME | |
| SCHEMBL14935818 | 0.86 | FOLH1 (0.46) | CPA3FOLH1MMEGAAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 363 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250339569-A1 | CARBONIC ANHYDRASE IX LIGANDS | 3B PHARMACEUTICALS GMBH (DE) | 2025-11-06 | — | — | US | claimed |
| US-12441765-B2 | Peptides and medical uses thereof | ANBITION S.R.L. (IT) | 2025-10-14 | — | — | US | claimed |
| WO-2025094171-A1 | SUPERHYDROPHOBIC COATING | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2025-05-08 | — | — | WO | claimed |
| CN-119565651-A | Modification method of Pd/C catalyst and application of Pd/C catalyst in hydrodehalogenation reaction | 江苏扬农化工集团有限公司 | 2025-03-07 | — | — | CN | claimed |
| CN-112996528-B | Peptides and medical uses thereof | 安必圣有限责任公司 | 2025-01-07 | — | — | CN | claimed |
| CN-113015539-B | Peptides and medical uses thereof | 安必圣有限责任公司 | 2025-01-07 | — | — | CN | claimed |
| WO-2024233569-A2 | METHODS AND COMPOSITIONS FOR REDUCING MALODOR | TAXA TECHNOLOGIES, INC. (US) | 2024-11-14 | — | — | WO | claimed |
| EP-3740586-B1 | SCREENING METHOD FOR SUBSTANCES REDUCING MALODOURS FROM EMANATIONS FROM A DOG | MARS INC (US) | 2024-11-13 | — | — | EP | claimed |
| EP-4448544-A2 | CARBONIC ANHYDRASE IX LIGANDS | 3B Pharmaceuticals GmbH (DE) | 2024-10-23 | — | — | EP | claimed |
| US-12084709-B2 | Screening method | MARS, INCORPORATED (US) | 2024-09-10 | — | — | US | claimed |
| US-20150175674-A1 | LIPIDATED PEPTIDES AS ANTI-OBESITY AGENTS | USTAV ORGANICKE CHEMIE A BIOCHEMIE AKADEMIE VED CR, v.v.i. (CZ) | 2015-06-25 | — | — | US | claimed |
| EP-2872124-A2 | LIPIDATED PEPTIDES AS ANTI-OBESITY AGENTS | Ustav Organicke Chemie A Biochemie Akademie Ved Cr, v.v.i. (CZ) | 2015-05-20 | — | — | EP | claimed |
| WO-2014134203-A9 | AMPHIPHILIC DERIVATIVES OF THIOETHER CONTAINING BLOCK COPOLYPEPTIDES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2014-10-23 | — | — | WO | claimed |
| WO-2014134203-A1 | AMPHIPHILIC DERIVATIVES OF THIOETHER CONTAINING BLOCK COPOLYPEPTIDES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2014-09-04 | — | — | WO | claimed |
| WO-2014118779-A1 | ANTIFOULING MATERIALS | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2014-08-07 | — | — | WO | claimed |
| WO-2014009808-A2 | LIPIDATED PEPTIDES AS ANTI-OBESITY AGENTS | USTAV ORGANICKE CHEMIE A BIOCHEMIE AKADEMIE VED CR, V.V.I (CZ) | 2014-01-16 | — | — | WO | claimed |
| WO-2007087572-A2 | AZA-PEPTIDE EPOXIDES | GEORGIA TECH RESEARCH CORPORATION (US) | 2007-08-02 | — | — | WO | claimed |
| WO-2004005270-A1 | AZA-PEPTIDE EPOXIDES | GEORGIA TECH RESEARCH CORPORATION (US) | 2004-01-15 | — | — | WO | claimed |
| WO-1997016201-A1 | ANGIOTENSIN IV AND ANALOGS AS REGULATORS OF FIBRINOLYSIS | BRIGHAM & WOMEN'S HOSPITAL (US) | 1997-05-09 | — | — | WO | claimed |
| WO-1995029691-A1 | PROLINE PHOSPHONATE DERIVATIVES | GEORGIA TECH RESEARCH CORPORATION (US) | 1995-11-09 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12441765-B2 | Peptides and medical uses thereof | FLT1, FLT4, TEK | CPA3 200/4885FOLH1 267/4885MME 182/4885 |
| US-20250339569-A1 | CARBONIC ANHYDRASE IX LIGANDS | CA9, CA13, CA4 | CPA3 43/4885FOLH1 36/4885MME 316/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.